Arwa Z Al-Riyami
Overview
Explore the profile of Arwa Z Al-Riyami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Srivastava P, Tewari A, Al-Riyami A
Vox Sang
. 2025 Mar;
PMID: 40045700
Background And Objectives: The recent rise of artificial intelligence (AI) chatbots has attracted many users worldwide. However, expert evaluation is essential before relying on them for transfusion medicine (TM)-related information....
2.
Mamo T, Al-Riyami A, Couto P, Weil B
Cytotherapy
. 2025 Feb;
PMID: 39918491
Background And Aim: The workforce landscape in the field of cell and gene therapy (CGT) continues to evolve. As new therapies receive approval and numerous clinical trials are underway, there...
3.
Al-Riyami A, Gammon R, Seheult J, Arora S, Goel R
Vox Sang
. 2025 Jan;
PMID: 39828246
Background And Objectives: Artificial intelligence (AI) has been gaining increasing interest in healthcare. During the 2024 International Society of Blood Transfusion (ISBT) Congress, the Clinical Transfusion Working Party (CTWP) conducted...
4.
Dhiman Y, Pavenski K, Patidar G, Triyono T, Sato T, Al-Riyami A, et al.
Vox Sang
. 2024 Nov;
120(1):80-88.
PMID: 39537336
No abstract available.
5.
Dhiman Y, Pavenski K, Patidar G, Triyono T, Sato T, Al-Riyami A, et al.
Vox Sang
. 2024 Nov;
120(1):89-103.
PMID: 39537247
No abstract available.
6.
Wolf J, Blais-Normandin I, Bathla A, Keshavarz H, Chou S, Al-Riyami A, et al.
Br J Haematol
. 2024 Nov;
206(1):94-108.
PMID: 39535318
Red blood cell (RBC) antigen matching beyond ABO and RhD is commonly recommended for patients with sickle cell disease (SCD) and thalassaemia. We present an updated systematic literature review to...
7.
So-Osman C, Burnouf T, Al-Riyami A, Bloch E, Estcourt L, Goel R, et al.
Front Immunol
. 2024 Sep;
15:1448720.
PMID: 39315108
Introduction: When Coronavirus Disease-19 (COVID-19) struck the world in December 2019, initiatives started to investigate the efficacy of convalescent plasma, a readily available source of passive antibodies, collected from recovered...
8.
Jacobs J, Bates I, Mbaya B, Eichbaum Q, Louw V, Al-Riyami A, et al.
N Engl J Med
. 2024 Aug;
391(12):1079-1081.
PMID: 39115103
No abstract available.
9.
Gammon R, Hindawi S, Al-Riyami A, Ang A, Bazin R, Bloch E, et al.
Transfus Med
. 2024 Aug;
34(5):333-343.
PMID: 39113629
Artificial intelligence (AI) uses sophisticated algorithms to "learn" from large volumes of data. This could be used to optimise recruitment of blood donors through predictive modelling of future blood supply,...
10.
Al-Riyami A, Hejres S, Elshafy S, Al Humaidan H, Samaha H
Vox Sang
. 2024 Jul;
119(9):973-980.
PMID: 39031656
Background And Objectives: Massive transfusion protocols (MTPs) are critical in managing haemorrhage, yet their utilization varies. There is lack of data on the utilization of MTPs in the Middle East...